Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Examples of Zero Based Budgeting success show practical wins and strategies you can implement in your own finances today.
17,347 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A pawn shop stock has surged 135% after a major fund disclosed a fresh $39 million stake. This article breaks down th...
As market conditions shift, financial institutions are prioritizing customer value matters more to shape loan product...
Spotify doubles down on internal mobility to fill roles, reporting strong Q1 2026 results and a low attrition rate am...
Many households earn more and still miss out on long-term wealth. This article uncovers the upper middle class trap a...
Entrepreneurship powered America’s rise, and Steve Case argues we must expand that engine nationwide to guard the cou...
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
A Goldman Sachs vice chair warns that as leaders rise, supervision fades and blind spots grow. The piece explores the...
Credo Technology delivers a blockbuster Q3, yet Marvell’s AI data-center push steals the spotlight. Investors are ret...
A notable fund trimmed its stake in Core Scientific while the stock jumped dramatically. This article breaks down wha...
At a Miami conference this week, Tom Lee floated a $22,000 Ethereum target, tying it to a mix of Bitcoin price milest...
Two billionaire investors, two very different plays on Alphabet. One backs a measured, Buffett-like approach; the oth...